1. Novel Advances in Understanding of Molecular Pathogenesis of Hepatoblastoma: A Wnt/β-Catenin Perspective
   Danielle Bell et al, 2017, Gene Expression CrossRef
2. Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
   Jose Marin et al, 2019, Cancers CrossRef
3. The Role of BH3-Mimetic Drugs in the Treatment of Pediatric Hepatoblastoma
   Justus Lieber et al, 2015, International Journal of Molecular Sciences CrossRef
4. ABT737 enhances cholangiocarcinoma sensitivity to cisplatin through regulation of mitochondrial dynamics
   Zhongqi Fan et al, 2015, Experimental Cell Research CrossRef
5. BH3-mimetic drugs prevent tumour onset in an orthotopic mouse model of hepatoblastoma
   Justus Lieber et al, 2014, Experimental Cell Research CrossRef
6. Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcoma
   Sarah Maria Johler et al, 2016, Cancer Immunology, Immunotherapy CrossRef
7. Hepatoblastoma: A Need for Cell Lines and Tissue Banks to Develop Targeted Drug Therapies
   Rishi Raj Rikhi et al, 2016, Frontiers in Pediatrics CrossRef
8. ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells
   Qi Xie et al, 2016, International Journal of Oncology CrossRef